{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-22-036148","form_type":"8-K","ticker":null,"cik":"0001138978","company_name":"Novo Integrated Sciences, Inc.","filed_at":"2022-12-21T23:59:59+00:00","discovered_at":"2026-05-14T18:03:49.728085+00:00","generated_at":"2026-06-21T00:41:22.575968+00:00","sec_items":["3.01","7.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Novo Integrated Sciences receives Nasdaq delisting notice for late 10-K filing","bullets":["Received Nasdaq notice on Dec 15, 2022 for failure to timely file Form 10-K for fiscal year ended Aug 31, 2022.","Has 60 days (until Feb 13, 2023) to submit a plan to regain compliance with Nasdaq Listing Rule 5250(c)(1).","If plan accepted, Nasdaq may grant up to 180 days (until June 12, 2023) to file the 10-K.","Company intends to file the Form 10-K as promptly as possible to regain compliance.","Ticker: NVOS; risk of delisting if not resolved."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-22-036148","json":"https://secwatch.observer/filing/0001493152-22-036148.json","markdown":"https://secwatch.observer/filing/0001493152-22-036148.md","text":"https://secwatch.observer/filing/0001493152-22-036148.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1138978/000149315222036148/0001493152-22-036148-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1138978/000149315222036148/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T00:41:22.575968+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3c4814a6ac4ffde5e335ca8d4f4dc9e4b6c183f6","claim":"Novo Integrated Sciences, Inc. received a nasdaq deficiency notice notice regarding late filing (rules 5250(c)(1)).","evidence_excerpt":"December 15, 2022, Novo Integrated Sciences, Inc. (the “Company”) today reported that it received a notice (the “Notice) on December 15, 2022 from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) advising the Company that it was not in compliance with Nasdaq’s continued listing requirements under Nasdaq Listing Rule 5250(c)(1) (the “Rule”) as a result of its failure to timely file its Annual Report on Form 10-K for the fiscal year ended August 31, 2022 (the “Form 10-K”). Under Nasdaq rules, the Company has 60 calendar days from receipt of the Notice or until Febr","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1138978/000149315222036148/0001493152-22-036148-index.htm","confidence":0.9,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"late filing"},{"label":"Rules","value":"5250(c)(1)"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}